Results 21 to 30 of about 278,985 (182)

Predictors of dopamine agonist resistance in prolactinoma patients

BMC Endocrine Disorders, 2020
Background Surgical resection of prolactinomas resistant to dopamine agonists is frequently incomplete due to fibrotic changes of the tumour under pharmacological therapy. In order to identify a subgroup of patients who may benefit from early surgery, we
Elle Vermeulen, Jean D’Haens, Tadeusz Stadnik, David Unuane, Kurt Barbe, Vera Van Velthoven, Sven Gläsker   +6 more
doaj   +1 more source

The effects of the dopamine agonist rotigotine on hemispatial neglect following stroke [PDF]

, 2012
Hemispatial neglect following right-hemisphere stroke is a common and disabling disorder, for which there is currently no effective pharmacological treatment. Dopamine agonists have been shown to play a role in selective attention and working memory, two
Kulinskaya, Elena, Singh-Curry, Victoria, Nair, Ajoy, Singh-Curry, V, Ward, N, Ward, Nick, Mah, Y-H, Mah, Yee-Haur, Greenwood, Richard, Cohen, D, Simister, R, Hadji-Michael, M, Greenwood, R, Cohen, David, Mah, YH, Machner, Bjoern, Husain, M, Malhotra, Paresh, Kulinskaya, E, Gorgoraptis, N, Gorgoraptis, Nikos, Machner, B, Malhotra, P, Nair, A, Hadji-Michael, Maria, Simister, Robert, Husain, Masud   +26 more
core   +1 more source

Clinical Aspects and Management of Levodopa-Induced Dyskinesia

Parkinson's Disease, 2012
In Parkinson's disease, one of the most troublesome dilemmas is the treatment of levodopa-induced dyskinesia. After a few years, chronic treatment with levodopa is associated with the development of dyskinesias.
Nicola Tambasco, Simone Simoni, Erica Marsili, Elisa Sacchini, Donatella Murasecco, Gabriela Cardaioli, Aroldo Rossi, Paolo Calabresi   +7 more
doaj   +1 more source

Dopamine agonists in prolactinomas

Endocrinology Research and Practice, 2022
-
Annamaria Colao
doaj   +2 more sources

A Review of Voltammetric Methods for Determination of Dopamine Agonists

, 2021
Background: Dopamine agonists are useful drugs for the management of patients with Parkinson's disease in the early and later stages of the disease. Parkinson's disease is a progressive neurodegenerative disease that primarily affects dopamine-producing ...
AĞIN, FATMA
core   +1 more source

A quantum chemical approach representing a new perspective concerning agonist and antagonist drugs in the context of schizophrenia and Parkinson's disease.

PLoS ONE, 2019
Schizophrenia and Parkinson's disease can be controlled with dopamine antagonists and agonists. In order to improve the understanding of the reaction mechanism of these drugs, in this investigation we present a quantum chemical study of 20 antagonists ...
Ana Martínez, Ilich A Ibarra, Rubicelia Vargas   +2 more
doaj   +1 more source

Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia

Frontiers in Pharmacology, 2020
Dopamine receptors are widely distributed within the brain where they play critical modulator roles on motor functions, motivation and drive, as well as cognition.
Jean Claude Martel, Silvia Gatti McArthur   +1 more
doaj   +1 more source

Treatment of hyperprolactinemia: a systematic review and meta-analysis

Systematic Reviews, 2012
Background Hyperprolactinemia is a common endocrine disorder that can be associated with significant morbidity. We conducted a systematic review and meta-analyses of outcomes of hyperprolactinemic patients, including microadenomas and macroadenomas, to ...
Wang Amy T, Mullan Rebecca J, Lane Melanie A, Hazem Ahmad, Prasad Chaithra, Gathaiya Nicola W, Fernández-Balsells M, Bagatto Amy, Coto-Yglesias Fernando, Carey Jantey, Elraiyah Tarig A, Erwin Patricia J, Gandhi Gunjan Y, Montori Victor M, Murad Mohammad   +14 more
doaj   +1 more source

Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma

Journal of Investigative Medicine High Impact Case Reports, 2021
Dopamine agonists are generally well tolerated and represent the first-line therapy for prolactinomas. We report a case of a 20-year-old man with a macroprolactinoma who developed recurrent priapism with cabergoline and bromocriptine.
Lakshmi P. Menon MD, Wedad Rahman MD
doaj   +1 more source

Progress in the study of Dopamine Receptor Agonists for Brain Protection after Ischemic Brain Injury

Zhongguo cuzhong zazhi
: Ischemic brain injury comprises 87% of all brain injuries and typically results in severe functional impairments. Dopamine, the most abundant catecholamine neurotransmitter in the brain, is intimately linked with autonomous movement, emotion, sleep ...
ZHANG Linyao1, LIU Lixu1,2
doaj   +1 more source